SCM
DXCM icon

Shelton Capital Management’s DexCom DXCM Stock Holding History

Shelton Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.73M Sell
55,318
-167
-0.3% -$11.1K 0.07% 172
2026
Q1 		$3.48M Sell
55,485
-918
-2% -$63.9K 0.08% 175
2025
Q4 		$3.74M Buy
56,403
+10,295
+22% +$666K 0.07% 181
2025
Q3 		$3.1M Sell
46,108
-16,311
-26% -$1.29M 0.07% 183
2025
Q2 		$5.45M Sell
62,419
-2,222
-3% -$174K 0.13% 149
2025
Q1 		$4.41M Sell
64,641
-1,743
-3% -$142K 0.11% 163
2024
Q4 		$5.16M Buy
66,384
+15
+0% +$1.11K 0.13% 150
2024
Q3 		$4.45M Buy
66,369
+16,025
+32% +$1.32M 0.11% 162
2024
Q2 		$5.71M Buy
50,344
+2,048
+4% +$259K 0.16% 136
2024
Q1 		$6.7M Buy
48,296
+727
+2% +$91.4K 0.19% 125
2023
Q4 		$5.9M Buy
47,569
+4,052
+9% +$414K 0.19% 133
2023
Q3 		$4.06M Buy
43,517
+9,340
+27% +$1.05M 0.15% 165
2023
Q2 		$4.39M Buy
34,177
+1,329
+4% +$161K 0.16% 137
2023
Q1 		$3.82M Buy
32,848
+2,380
+8% +$266K 0.16% 140
2022
Q4 		$3.45M Sell
30,468
-6,552
-18% -$719K 0.36% 86
2022
Q3 		$2.98M Buy
37,020
+1,220
+3% +$103K 0.14% 158
2022
Q2 		$2.67M Hold
35,800
– – 0.12% 180
2022
Q1 		$4.58M Hold
35,800
– – 0.17% 134
2021
Q4 		$4.81M Buy
35,800
+1,316
+4% +$189K 0.17% 134
2021
Q3 		$4.71M Buy
34,484
+808
+2% +$102K 0.18% 122
2021
Q2 		$3.6M Hold
33,676
– – 0.14% 167
2021
Q1 		$3.03M Buy
33,676
+3,080
+10% +$289K 0.11% 189
2020
Q4 		$2.83M Buy
30,596
+1,180
+4% +$105K 0.13% 165
2020
Q3 		$3.03M Hold
29,416
– – 0.13% 185
2020
Q2 		$2.98M Buy
+29,416
New +$2.63M 0.16% 121

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Shelton Capital Management's DXCM Position: Q2 2026 in Review

Shelton Capital Management reduced its DexCom (DXCM) stake by 0.3% in Q2 2026, selling an estimated $11.1K and leaving 55,318 shares worth $3.73M. The position accounts for 0.07% of the portfolio, ranked #172.

Shelton Capital Management first reported a position in DXCM in Q2 2020 and has held it in 25 quarters since. The position peaked at $6.7M in Q1 2024. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Shelton Capital Management held 55,318 shares of DexCom worth $3.73M as of Q2 2026.
  • Shelton Capital Management sold 167 DexCom shares in Q2 2026, an estimated $11.1K.
  • DexCom made up 0.07% of Shelton Capital Management's portfolio in Q2 2026, its #172 holding.
  • Shelton Capital Management first reported a position in DexCom in Q2 2020 and has held it in 25 quarters since.
  • Shelton Capital Management's DexCom position peaked at $6.7M in Q1 2024.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Shelton Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.